Spyre Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC SYRE

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

600,455

Value ($000)

271

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	271	0.0%	600,455	6/30/2023
2023 Q1	5/15/2023	174	0.0%	600,455	3/31/2023
2022 Q4	2/13/2023	270	0.0%	600,455	12/31/2022
2022 Q3	11/14/2022	207	0.0%	394,020	9/30/2022
2022 Q2	8/12/2022	199	0.0%	394,020	6/30/2022
2022 Q1	5/13/2022	1,592	0.0%	692,221	3/31/2022
2021 Q4	2/11/2022	3,257	0.0%	685,745	12/31/2021
2021 Q3	11/12/2021	5,485	0.0%	689,997	9/30/2021
2021 Q2	8/13/2021	4,716	0.0%	677,726	6/30/2021
2021 Q1	5/12/2021	5,210	0.0%	657,870	3/31/2021
2020 Q4	2/12/2021	4,462	0.0%	567,013	12/31/2020
2020 Q3	11/13/2020	4,030	0.0%	568,458	9/30/2020
2020 Q2	8/13/2020	5,389	0.0%	582,644	6/30/2020
2020 Q1	5/14/2020	1,486	0.0%	319,080	3/31/2020
2019 Q4	2/13/2020	2,392	0.0%	313,171	12/31/2019